ICUI Icu Medical Inc

Price (delayed)

$243.08

Market cap

$5.16B

P/E Ratio

49.61

Dividend/share

N/A

EPS

$4.9

Enterprise value

$4.69B

ICU Medical, Inc. develops, manufactures and sells innovative medical products used in infusion therapy and critical care applications. ICU Medical's product portfolio includes IV smart pumps, sets, connectors, closed system ...

Highlights
The debt has dropped by 100% year-on-year
ICUI's quick ratio has surged by 78% year-on-year and by 5% since the previous quarter
The stock's P/E is 32% below its 5-year quarterly average of 73.2 but 6% above its last 4 quarters average of 46.6

Key stats

What are the main financial stats of ICUI
Market
Shares outstanding
21.21M
Market cap
$5.16B
Enterprise value
$4.69B
Valuations
Price to earnings (P/E)
49.61
Price to book (P/B)
3.31
Price to sales (P/S)
4.03
EV/EBIT
39.34
EV/EBITDA
21.71
EV/Sales
3.67
Earnings
Revenue
$1.28B
EBIT
$119.31M
EBITDA
$216.15M
Free cash flow
$174.73M
Per share
EPS
$4.9
Free cash flow per share
$8.24
Book value per share
$73.39
Revenue per share
$60.32
TBVPS
$74.54
Balance sheet
Total assets
$1.8B
Total liabilities
$245.58M
Debt
$0
Equity
$1.56B
Working capital
$789.69M
Liquidity
Debt to equity
0
Current ratio
5.3
Quick ratio
3.25
Net debt/EBITDA
-2.14
Margins
EBITDA margin
16.9%
Gross margin
36.8%
Net margin
8.1%
Operating margin
9.4%
Efficiency
Return on assets
5.8%
Return on equity
6.8%
Return on invested capital
12.7%
Return on capital employed
7.4%
Return on sales
9.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ICUI stock price

How has the Icu Medical stock price performed over time
Intraday
-0.33%
1 week
-3.65%
1 month
26.91%
1 year
27.01%
YTD
13.33%
QTD
18.11%

Financial performance

How have Icu Medical's revenue and profit performed over time
Revenue
$1.28B
Gross profit
$470.01M
Operating income
$119.89M
Net income
$103.26M
Gross margin
36.8%
Net margin
8.1%
ICUI's net income is up by 24% year-on-year and by 10% since the previous quarter
The net margin has increased by 23% year-on-year and by 9% since the previous quarter
The operating income has grown by 21% year-on-year and by 11% since the previous quarter
The operating margin has grown by 19% YoY and by 11% from the previous quarter

Growth

What is Icu Medical's growth rate over time

Valuation

What is Icu Medical stock price valuation
P/E
49.61
P/B
3.31
P/S
4.03
EV/EBIT
39.34
EV/EBITDA
21.71
EV/Sales
3.67
The stock's P/E is 32% below its 5-year quarterly average of 73.2 but 6% above its last 4 quarters average of 46.6
ICUI's EPS is up by 22% YoY and by 10% from the previous quarter
The stock's price to book (P/B) is 18% more than its last 4 quarters average of 2.8
Icu Medical's equity has increased by 10% YoY and by 2.4% QoQ
ICUI's P/S is 19% more than its last 4 quarters average of 3.4 and 6% more than its 5-year quarterly average of 3.8

Efficiency

How efficient is Icu Medical business performance
The ROIC has grown by 25% YoY and by 14% from the previous quarter
ICUI's return on assets is up by 23% year-on-year and by 9% since the previous quarter
ICUI's ROS is up by 21% YoY and by 11% from the previous quarter
Icu Medical's ROE has increased by 13% YoY and by 6% from the previous quarter

Dividends

What is ICUI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ICUI.

Financial health

How did Icu Medical financials performed over time
The current ratio has soared by 83% year-on-year and by 2.7% since the previous quarter
ICUI's quick ratio has surged by 78% year-on-year and by 5% since the previous quarter
The debt is 100% smaller than the equity
The debt to equity has dropped by 100% year-on-year
The debt has dropped by 100% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.